Bladder Cancer Clinical Trial
ADSTILADRIN Early Utilization and Outcomes in the Real World Setting in the United States
Summary
Multi-center, prospective non-interventional study to collect data on the early use of ADSTILADRIN in the US. Data will be collected from participants, caregivers and prescribing physicians in a real-world setting.
Eligibility Criteria
Inclusion Criteria:
Prescribed and scheduled treatment with ADSTILADRIN per physician discretion or received the first instillation of ADSTILADRIN per physician discretion after 5 September 2023 but prior to site activation
Signed and dated ICF.
Age 18 years or older at day ICF is signed.
Exclusion Criteria:
Currently enrolled in a clinical trial.
Participants who have previously been treated with ADSTILADRIN in the context of a clinical trial
Participant is pregnant or breastfeeding.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 14 Locations for this study
Gilbert Arizona, 85234, United States More Info
Contact
Little Rock Arkansas, 72211, United States
Los Angeles California, 90033, United States
Gainesville Florida, 32608, United States
Greenwood Indiana, 46143, United States More Info
Contact
Jeffersonville Indiana, 47130, United States
Wichita Kansas, 67226, United States
Rochester Minnesota, 55905, United States
Syracuse New York, 13210, United States
Gahanna Ohio, 43230, United States More Info
Contact
Myrtle Beach South Carolina, 29572, United States More Info
Contact
Nashville Tennessee, 37209, United States
Charlottesville Virginia, 22908, United States More Info
Contact
Virginia Beach Virginia, 23462, United States
How clear is this clinincal trial information?